Product Overview
Tirzepatide Dual GIP/GLP-1 Receptor Agonist Peptide
High-quality Tirzepatide for dual receptor agonists and laboratory analytical research
Tirzepatide is supplied as a dual gip/glp-1 receptor agonist peptide for qualified laboratory research. It is intended for laboratory studies of dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor signalling, receptor selectivity and incretin pathway biology. Available specifications: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 60 mg, 65 mg, 80 mg, 100 mg; 10 vials per box. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Synonym(s): Tirzepatide; LY3298176
Packaging & Availability
Pricing is supplied on request. Select one or more pack sizes to add them to your quote cart.
| Select | SKU | Pack Size | Availability | Price |
|---|---|---|---|---|
| TR5 | 5mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR10 | 10mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR15 | 15mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR20 | 20mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR30 | 30mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR35 | 35mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR40 | 40mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR50 | 50mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR60 | 60mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR65 | 65mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR80 | 80mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request | |
| TR100 | 100mg/vial | 10vial/box;M0Q:100boxes or 1000vial | On request |
Product Overview
Tirzepatide is a modified peptide used in laboratory studies of dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor signalling, receptor selectivity and incretin pathway biology. The material is intended for qualified research organisations, analytical laboratories and product-development teams. It is supplied under batch-controlled conditions, and the final website specification must match the released COA.
Key Features
- Product type: Dual GIP/GLP-1 Receptor Agonist Peptide
- Available specifications: 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 60 mg, 65 mg, 80 mg, 100 mg; 10 vials per box
- Purity / grade: Research grade; enter the exact HPLC purity shown on the batch COA
- Appearance: White to off-white lyophilized powder; confirm against the batch COA
- Documentation: Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable
- Bulk supply and custom labelling are available subject to technical and compliance review
Research Applications
Typical non-clinical research use includes dual receptor agonists, receptor or enzyme assays, peptide or small-molecule characterisation, chromatographic method development, mass-spectrometric confirmation, stability assessment and formulation compatibility studies. Researchers should determine suitability for their own protocol.
Supply & Quality Documentation
Batch-specific quality documentation is available according to the selected grade and order. Technical values shown on the website should be reconciled with the final COA, HPLC and MS results before release.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a modified peptide used in laboratory studies of dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor signalling, receptor selectivity and incretin pathway biology. It is supplied solely for qualified laboratory research.
What specifications are available for Tirzepatide?
Current catalogue specifications are 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 60 mg, 65 mg, 80 mg, 100 mg; 10 vials per box. Final availability must be confirmed when requesting a quotation.
What purity is supplied?
Research grade; enter the exact HPLC purity shown on the batch COA. The batch COA is the controlling quality record.
Which quality documents are available?
Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable. Document availability depends on the selected grade and batch.
How should Tirzepatide be stored?
Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
Is Tirzepatide intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Product Properties
| Product Name | Tirzepatide |
|---|---|
| Product Type | Dual GIP/GLP-1 Receptor Agonist Peptide |
| Main Category | Metabolic Peptides |
| Subcategory | Dual Receptor Agonists |
| Available Specifications | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 35 mg, 40 mg, 45 mg, 50 mg, 60 mg, 65 mg, 80 mg, 100 mg; 10 vials per box |
| Purity / Grade | Research grade; enter the exact HPLC purity shown on the batch COA |
| Appearance | White to off-white lyophilized powder; confirm against the batch COA |
| Storage | Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles. |
| Quality Documents | Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable |
Analytical & Research Scope
Tirzepatide may be used for laboratory studies of dual glucose-dependent insulinotropic polypeptide and GLP-1 receptor signalling, receptor selectivity and incretin pathway biology. The purchaser is responsible for validating the material in the intended laboratory method.
Ordering Information
Please specify the required content, batch quantity, target purity, destination country, packaging format and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
- Read the batch-specific Safety Data Sheet before handling.
- Use suitable laboratory gloves, protective clothing and eye protection.
- Avoid inhalation, ingestion and direct contact with skin or eyes.
- Use only in a controlled laboratory environment with appropriate engineering controls.
- Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
- Dispose of unused material, containers and solutions in accordance with institutional and local regulations.
No clinical dosing, treatment or consumer-use information is provided.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.